Cognitive enhancers for the treatment of ADHD - PubMed (original) (raw)

Review

Cognitive enhancers for the treatment of ADHD

L Cinnamon Bidwell et al. Pharmacol Biochem Behav. 2011 Aug.

Abstract

Attention-deficit hyperactivity disorder (ADHD) is associated with multiple cognition-related phenotypic features in both children and adults. This review aims to clarify the role of cognition in ADHD and how prevailing treatments, which are often highly effective at reducing the clinical symptoms of the disorder, fare in modulating ADHD-related cognitive processes. First, we consider how the broad construct of cognition can be conceptualized in the context of ADHD. Second, we review the available evidence for how a range of both pharmacological and non-pharmacological interventions have fared with respect to enhancing cognition in individuals affected by this pervasive disorder. Findings from the literature suggest that the effects across a broad range of pharmacological and non-pharmacological interventions on the characteristic symptoms of ADHD can be distinguished from their effects on cognitive impairments. As such the direct clinical relevance of cognition enhancing effects of different interventions is somewhat limited. Recommendations for future research are discussed, including the identification of cognition-related endophenotypes, the refinement of the ADHD clinical phenotype, and studying the difference between acute and chronic treatment regimens.

PubMed Disclaimer

Cited by

Chronic Cocaine Use and Parkinson's Disease: An Interpretative Model.
Carbone MG, Maremmani I. Carbone MG, et al. Int J Environ Res Public Health. 2024 Aug 21;21(8):1105. doi: 10.3390/ijerph21081105. Int J Environ Res Public Health. 2024. PMID: 39200714 Free PMC article. Review.
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity.
Sikiric P, Boban Blagaic A, Strbe S, Beketic Oreskovic L, Oreskovic I, Sikiric S, Staresinic M, Sever M, Kokot A, Jurjevic I, Matek D, Coric L, Krezic I, Tvrdeic A, Luetic K, Batelja Vuletic L, Pavic P, Mestrovic T, Sjekavica I, Skrtic A, Seiwerth S. Sikiric P, et al. Pharmaceuticals (Basel). 2024 Apr 3;17(4):461. doi: 10.3390/ph17040461. Pharmaceuticals (Basel). 2024. PMID: 38675421 Free PMC article. Review.
Retinal Changes in Parkinson's Disease: A Non-invasive Biomarker for Early Diagnosis.
Subramaniam MD, Aishwarya Janaki P, Abishek Kumar B, Gopalarethinam J, Nair AP, Mahalaxmi I, Vellingiri B. Subramaniam MD, et al. Cell Mol Neurobiol. 2023 Nov;43(8):3983-3996. doi: 10.1007/s10571-023-01419-4. Epub 2023 Oct 13. Cell Mol Neurobiol. 2023. PMID: 37831228 Review.
Something to Snack on: Can Dietary Modulators Boost Mind and Body?
Guillaumin MCC, Syarov B, Burdakov D, Peleg-Raibstein D. Guillaumin MCC, et al. Nutrients. 2023 Mar 10;15(6):1356. doi: 10.3390/nu15061356. Nutrients. 2023. PMID: 36986089 Free PMC article.
Mood and behavior regulation: interaction of lithium and dopaminergic system.
Mohamadian M, Fallah H, Ghofrani-Jahromi Z, Rahimi-Danesh M, Shokouhi Qare Saadlou MS, Vaseghi S. Mohamadian M, et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Jul;396(7):1339-1359. doi: 10.1007/s00210-023-02437-1. Epub 2023 Feb 27. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36843130 Review.

References

1. Addy NA, Nakijama A, Levin ED. Nicotinic mechanisms of memory: effects of acute local DHbetaE and MLA infusions in the basolateral amygdala. Brain Res Cogn Brain Res. 2003;16:51–57. - PubMed
1. Advokat C. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD) Neurosci Biobehav Rev. 2010;34:1256–1266. - PubMed
1. Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:841–845. - PubMed
1. Amiri S, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Kahbazi M, Akhondzadeh S. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:145–149. - PubMed
1. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56:1073–1086. - PubMed

Cognitive enhancers for the treatment of ADHD - PubMed (original) (raw)